Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Ancestral susceptibility to colorectal cancer.

Huhn S, Pardini B, Naccarati A, Vodicka P, Hemminki K, Försti A.

Mutagenesis. 2012 Mar;27(2):197-204. doi: 10.1093/mutage/ger061.

PMID:
22294767
2.

Diet and colorectal cancer: implications for the obese and devotees of the Atkins diet.

Fleming ME, Sales KM, Winslet MC.

Colorectal Dis. 2005 Mar;7(2):128-32. Review.

PMID:
15720348
3.

Life style-related diseases of the digestive system: colorectal cancer as a life style-related disease: from carcinogenesis to medical treatment.

Takahashi H, Yoneda K, Tomimoto A, Endo H, Fujisawa T, Iida H, Mawatari H, Nozaki Y, Ikeda T, Akiyama T, Yoneda M, Inamori M, Abe Y, Saito S, Nakajima A, Nakagama H.

J Pharmacol Sci. 2007 Oct;105(2):129-32. Epub 2007 Oct 6. Review.

4.

Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study.

Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ 3rd, Sellers TA, Cerhan JR.

Am J Gastroenterol. 2006 Aug;101(8):1872-9. Epub 2006 Jun 22.

PMID:
16790032
5.

Risk factors for sessile serrated adenomas.

Anderson JC, Rangasamy P, Rustagi T, Myers M, Sanders M, Vaziri H, Wu G, Birk JW, Protiva P.

J Clin Gastroenterol. 2011 Sep;45(8):694-9. doi: 10.1097/MCG.0b013e318207f3cf.

PMID:
21325950
6.

Family history, metabolic gene polymorphism, diet and risk of colorectal cancer.

Little J, Faivre J.

Eur J Cancer Prev. 1999 Dec;8 Suppl 1:S61-72. Review.

PMID:
10772420
7.

Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men.

Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, Limburg PJ, Gapstur SM.

Gastroenterology. 2010 Oct;139(4):1138-46. doi: 10.1053/j.gastro.2010.06.072. Epub 2010 Jul 13.

PMID:
20633560
8.

Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.

Giouleme O, Diamantidis MD, Katsaros MG.

World J Gastroenterol. 2011 Jan 28;17(4):444-8. doi: 10.3748/wjg.v17.i4.444. Review.

9.

Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.

Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CP, Nicodemus KK, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):133-7.

10.

Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results.

Vasků A, Vokurka J, Bienertová-Vasků J.

Int J Colorectal Dis. 2009 Mar;24(3):289-94. doi: 10.1007/s00384-008-0553-6. Epub 2008 Aug 15.

PMID:
18704460
11.

Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer risk.

Pardini B, Naccarati A, Vodicka P, Kumar R.

Mutagenesis. 2012 Mar;27(2):161-7. doi: 10.1093/mutage/ger057. Review.

PMID:
22294763
12.

Impaired glucose metabolism in colorectal cancer.

Ehrmann-Jósko A, Siemińska J, Górnicka B, Ziarkiewicz-Wróblewska B, Ziółkowski B, Muszyński J.

Scand J Gastroenterol. 2006 Sep;41(9):1079-86.

PMID:
16938722
13.

Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.

Pechlivanis S, Pardini B, Bermejo JL, Wagner K, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Försti A.

Endocr Relat Cancer. 2007 Sep;14(3):733-40.

14.

Obesity, type 2 diabetes and risk of digestive cancer.

Hillon P, Guiu B, Vincent J, Petit JM.

Gastroenterol Clin Biol. 2010 Oct;34(10):529-33. doi: 10.1016/j.gcb.2010.07.021. Review.

15.

Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk.

Suchy J, Kłujszo-Grabowska E, Kładny J, Cybulski C, Wokołorczyk D, Szymańska-Pasternak J, Kurzawski G, Scott RJ, Lubiński J.

BMC Cancer. 2008 Apr 23;8:112. doi: 10.1186/1471-2407-8-112.

16.

Diet and lifestyle in the prevention of colorectal cancer: an overview.

Shike M.

Am J Med. 1999 Jan 25;106(1A):11S-15S; discussion 50S-51S. Review.

PMID:
10089108
17.

Recent advances in understanding the role of diet and obesity in the development of colorectal cancer.

Lund EK, Belshaw NJ, Elliott GO, Johnson IT.

Proc Nutr Soc. 2011 May;70(2):194-204. doi: 10.1017/S0029665111000073. Epub 2011 Mar 9. Review.

PMID:
21385524
18.

Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility.

Lascorz J, Försti A, Chen B, Buch S, Steinke V, Rahner N, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Schulmann K, Goecke T, Kloor M, Engel C, Büttner R, Kunkel N, Weires M, Hoffmeister M, Pardini B, Naccarati A, Vodickova L, Novotny J, Schreiber S, Krawczak M, Bröring CD, Völzke H, Schafmayer C, Vodicka P, Chang-Claude J, Brenner H, Burwinkel B, Propping P, Hampe J, Hemminki K.

Carcinogenesis. 2010 Sep;31(9):1612-9. doi: 10.1093/carcin/bgq146. Epub 2010 Jul 7.

PMID:
20610541
19.

Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China.

Ren X, Zhang X, Zhang X, Gu W, Chen K, Le Y, Lai M, Zhu Y.

Public Health. 2009 Aug;123(8):540-4. doi: 10.1016/j.puhe.2009.06.019. Epub 2009 Aug 6.

PMID:
19664792
20.

Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies.

Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J.

Eur J Epidemiol. 2011 Nov;26(11):863-76. doi: 10.1007/s10654-011-9617-y. Epub 2011 Sep 22. Review.

PMID:
21938478

Supplemental Content

Support Center